Connect with us

Hi, what are you looking for?

Your Retire Invest

Economy

“No More Nasal Relief: CVS Health Is Saying Goodbye to Phenylephrine!”

CVS Health announced on Tuesday that it will no longer sell decongestants that contain phenylephrine in its stores and on its website. The move follows the company’s decision to take steps to reduce the number of products on its shelves that are considered unsafe and potentially harmful.

The decongestant in question, phenylephrine, is found in over-the-counter cold remedies like nasal sprays, tablets, and liquid medicines. It is often used as a decongestant to reduce nasal congestion associated with colds and allergies.

However, the FDA has advised that phenylephrine can be potentially dangerous to some people, as it can cause elevated blood pressure, heart palpitations, and even stroke in certain individuals. In addition, the FDA has warned against exceeding certain recommended dosage levels when taken in combination with certain medications.

In an effort to protect its customers, CVS Health is now pulling all products containing phenylephrine from its shelves and removing them from its online store. The company says it wants to provide safe and effective medications and products to customers while helping to ensure that these products are used as intended.

In an effort to further reduce potential risks, CVS Health is also replacing those products with decongestants that contain other active ingredients, such as pseudoephedrine or pseudoephedrine HCI. Products with these active ingredients are often just as effective but are not linked to the same risks.

By taking proactive steps to reduce the risk of dangerous products being sold in its stores, CVS Health is demonstrating its commitment to the safety and well-being of its customers. This is just one of the many initiatives CVS Health has taken to protect the safety of its customers, and it is an example of a company taking the steps necessary to protect the health of its customers.

You May Also Like

Editor's Pick

Controversy ensued recently when a vocal group within the Republican party (in the United States) began to make the argument that the Speaker position,...

Stock

In this edition of StockCharts TV‘s The Final Bar, Dave shows how breadth conditions have evolved so far in August, highlights the renewed strength in the...

Top News

Intensified aerial strikes in and around the Hamas-controlled Gaza Strip have been met with retaliatory releases of Israeli hostages by the militant organization. On...

Economy

In an effort to promote stronger loyalty among customers, Delta Air Lines has recently announced changes that will make it more difficult to earn...

Disclaimer: YourRetireInvest.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 YourRetireInvest. All Rights Reserved.